These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27974996)

  • 1. Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study.
    Flores GP; Peace B; Carnes TC; Baumgartner SL; Buffkin DE; Euliano NR; Smith LN
    Innov Clin Neurosci; 2016; 13(9-10):12-19. PubMed ID: 27974996
    [No Abstract]   [Full Text] [Related]  

  • 2. A Novel Digital Pill System for Medication Adherence Measurement and Reporting: Usability Validation Study.
    Baumgartner SL; Buffkin DE; Rukavina E; Jones J; Weiler E; Carnes TC
    JMIR Hum Factors; 2021 Nov; 8(4):e30786. PubMed ID: 34747709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.
    Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G
    J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants.
    Eisenberger U; Wüthrich RP; Bock A; Ambühl P; Steiger J; Intondi A; Kuranoff S; Maier T; Green D; DiCarlo L; Feutren G; De Geest S
    Transplantation; 2013 Aug; 96(3):245-50. PubMed ID: 23823651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy.
    Belknap R; Weis S; Brookens A; Au-Yeung KY; Moon G; DiCarlo L; Reves R
    PLoS One; 2013; 8(1):e53373. PubMed ID: 23308203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform.
    Browne SH; Behzadi Y; Littlewort G
    JMIR Mhealth Uhealth; 2015 Dec; 3(4):e108. PubMed ID: 26721413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formative Perceptions of a Digital Pill System to Measure Adherence to Heart Failure Pharmacotherapy: Mixed Methods Study.
    Chai PR; Kaithamattam JJ; Chung M; Tom JJ; Goodman GR; Hasdianda MA; Carnes TC; Vaduganathan M; Scirica BM; Schnipper JL
    JMIR Cardio; 2024 Feb; 8():e48971. PubMed ID: 38358783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period.
    Profit D; Rohatagi S; Zhao C; Hatch A; Docherty JP; Peters-Strickland TS
    J Clin Psychiatry; 2016 Sep; 77(9):e1095-e1100. PubMed ID: 27379966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings.
    Chai PR; Goodman G; Bustamante MJ; Mohamed Y; Castillo-Mancilla J; Boyer EW; Mayer KH; Rosen RK; Baumgartner SL; Buffkin E; O'Cleirigh C
    J Pharm Technol; 2021 Jun; 37(3):135-139. PubMed ID: 34752557
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.
    Kopelowicz A; Baker RA; Zhao C; Brewer C; Lawson E; Peters-Strickland T
    Neuropsychiatr Dis Treat; 2017; 13():2641-2651. PubMed ID: 29089771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wirelessly Observed Therapy to Optimize Adherence and Target Interventions for Oral Hepatitis C Treatment: Observational Pilot Study.
    Bonacini M; Kim Y; Pitney C; McKoin L; Tran M; Landis C
    J Med Internet Res; 2020 Feb; 22(2):e15532. PubMed ID: 32352385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.
    Peters-Strickland T; Pestreich L; Hatch A; Rohatagi S; Baker RA; Docherty JP; Markovtsova L; Raja P; Weiden PJ; Walling DP
    Neuropsychiatr Dis Treat; 2016; 12():2587-2594. PubMed ID: 27785036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ingestible electronic sensors to measure instantaneous medication adherence: A narrative review.
    Chai PR; Vaz C; Goodman GR; Albrechta H; Huang H; Rosen RK; Boyer EW; Mayer KH; O'Cleirigh C
    Digit Health; 2022; 8():20552076221083119. PubMed ID: 35251683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a Digital Medication Management System for Effective Assessment and Enhancement of Patient Adherence to Therapy (ReX): Feasibility Study.
    Shtrichman R; Conrad S; Schimo K; Shachar R; Machluf E; Mindal E; Epstein H; Epstein S; Paz A
    JMIR Hum Factors; 2018 Nov; 5(4):e10128. PubMed ID: 30478020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study.
    Chai PR; Bustamante MJ; Goodman G; Mohamed Y; Najarro J; Sullivan MC; Castillo-Mancilla J; Coyle RP; Mayer KH; Rosen RK; Baumgartner SL; Alpert PE; Boyer EW; O'Cleirigh C
    JMIR Form Res; 2021 Apr; 5(4):e26213. PubMed ID: 33890863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing an Ingestible Biosensor to Assess Real-Time Medication Adherence.
    Chai PR; Castillo-Mancilla J; Buffkin E; Darling C; Rosen RK; Horvath KJ; Boudreaux ED; Robbins GK; Hibberd PL; Boyer EW
    J Med Toxicol; 2015 Dec; 11(4):439-44. PubMed ID: 26245878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Adherence Measurement Using an Ingestible Sensor Compared With Self-Reporting in High-Risk Cardiovascular Disease Patients Who Knew They Were Being Measured: A Prospective Intervention.
    Thompson D; Mackay T; Matthews M; Edwards J; Peters NS; Connolly SB
    JMIR Mhealth Uhealth; 2017 Jun; 5(6):e76. PubMed ID: 28606895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary feasibility of a wrist-worn receiver to measure medication adherence via an ingestible radiofrequency sensor.
    Goldfine CE; Albrechta H; O'Cleirigh C; Standley A; Mohamed Y; Hokayem J; Lee JS; Carnes TC; Goodman GR; Mayer KH; Alpert P; Chai PR
    Int Conf Wearable Implant Body Sens Netw; 2023 Oct; 2023():. PubMed ID: 38155876
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.